Results 181 to 190 of about 163,677 (304)

Is there a role for cannabidiol in obesity, metabolic syndrome and binge eating?

British Journal of Pharmacology, EarlyView.
Cannabidiol (CBD) is one of the most abundant phytocannabinoids isolated from the Cannabis sativa plant. CBD is a lipophilic, non‐intoxicating substance that differently from Δ9‐tetrahydrocannabinol (Δ9‐THC) does not present the typical profile of a drug of abuse.
Luca Botticelli, Emanuela Micioni Di Bonaventura, Giacomo Einaudi, Gustavo Provensi, Alessia Costa, Claudio D'Addario, Carlo Cifani, Maria Vittoria Micioni Di Bonaventura   +7 more
wiley   +1 more source

Levamisole-Adulterated Cocaine-Associated Vasculopathy in a 73-Year-Old Woman: Diagnostic Challenges in Primary Care. [PDF]

Cureus
Torres Costa Lino T, Linares AL, Peterkin-McCalman R, Bryant W.   +3 more
europepmc   +1 more source

Gut microbiota as a novel therapeutic target for eating disorders and obesity

British Journal of Pharmacology, EarlyView.
The graphical abstract highlights the bidirectional interaction between the gut microbiota and central homeostatic and hedonic mechanisms regulating food intake, which contributes to overweight and obesity. It also illustrates emerging microbiota‐based biomarkers and therapeutic strategies (including prebiotics, probiotics, postbiotics, synbiotics and ...
Solveiga Samulėnaitė, Victor Mathis, Emmanuel Darcq, Aurelijus Burokas, Elena Martín‐García, Rafael Maldonado   +5 more
wiley   +1 more source

Intraspinal Cocainization [PDF]

BMJ, 1904
openaire   +2 more sources

Signal detection and characterisation of a novel drug–drug interaction between methadone and a synthetic cannabinoid receptor agonist

British Journal of Pharmacology, EarlyView.
Background and Purpose Little is known about how synthetic cannabinoid receptor agonist (SCRA) co‐use with other psychoactive substances may exacerbate risk of death. This study aimed to characterise the polypharmacy of deaths where SCRAs were detected at post‐mortem, investigate the cardiotoxicity of SCRAs and probe their inhibition of human ether‐a ...
Kirsten L. Rock, Louise M. Hesketh, Hongwei Cheng, Shuoqi Chen, Simon Hudson, Graeme Henderson, Jules C. Hancox, Michael J. Shattock, Michael J. Curtis, Caroline S. Copeland   +9 more
wiley   +1 more source

The dual incretin agonist tirzepatide blunts nicotine‐induced behaviours and neurochemistry in male mice

British Journal of Pharmacology, EarlyView.
Abstract Background and Purpose Nicotine dependence remains one of the leading causes of morbidity and mortality worldwide, with high relapse rates and post‐cessation weight gain representing persistent barriers to sustained abstinence. The incretin hormones glucose‐dependent insulinotropic polypeptide (GIP) and glucagon‐like peptide‐1 (GLP‐1) have ...
Christian E. Edvardsson, Thaynnam A. Emous, Sarah Witley, Mia Ericson, Louise Adermark, Elisabet Jerlhag   +5 more
wiley   +1 more source

Repeated measures latent class analysis identifies unique daily cocaine-use patterns and associated clinical characteristics: A timeline followback-based analytic approach. [PDF]

Drug Alcohol Depend Rep
Mascarin AT, Burstein W, Grasser LR, Greenwald MK.   +3 more
europepmc   +1 more source

Perinatal, socioenvironmental, and neurological factors to predict motor delay in infants born preterm

Developmental Medicine &Child Neurology, EarlyView.
Abstract Aim To determine the best combination of perinatal characteristics, socioenvironmental factors, and neurological examination at term‐equivalent age for identifying motor delay at 3 months 2 weeks corrected age in infants born preterm between 29 weeks and 36 weeks of gestation.
Melanie Gagnon, Mathieu Dehaes, Mi‐Suk Kang Dufour, Marie‐Michèle Gagnon, Gabriel Côté‐Corriveau, Leanne Brabant, Sophie Tremblay, Thuy Mai Luu, Marie‐Noelle Simard   +8 more
wiley   +1 more source

Agomelatine decreased cocaine-induced locomotor activity in rats; a dose-time response study. [PDF]

Front Pharmacol
Barbosa-Mendez S, Salazar-Juárez A.
europepmc   +1 more source

Increase in drug overdose deaths involving cocaine : United States, 2009\u20132018

Data from the National Vital Statistics System, Mortality\u2022 The rate of drug overdose deaths involving cocaine was stable between 2009 and 2013, then nearly tripled from 1.6 per 100,000 in 2013 to 4.5 in 2018.\u2022 In 2018, rates were highest for ...

core